Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

CCHR Condemns FDA's Approval of Electricity-Zapping for 'ADHD' Kids

Mental health watchdog group says electrical "treatment" creates harm


News provided by

Citizens Commission on Human Rights

May 01, 2019, 14:15 ET

Share this article

Share toX

Share this article

Share toX

LOS ANGELES, May 1, 2019 /PRNewswire/ -- The Food and Drug Administration (FDA) has approved a device to zap a low-level electrical pulse through the forehead of 7-12 year olds as treatment for Attention Deficit Hyperactivity Disorder (ADHD).[1] But the mental health watchdog, Citizens Commission on Human Rights International (CCHR), says with concern that some psychiatrists have now turned to the FDA to approve a device that "electro-shocks children into docility."

Continue Reading
Mental health watchdog group says electrical "treatment" creates harm
Mental health watchdog group says electrical "treatment" creates harm

The Monarch eTNS System device costs around $1,000, according to CNN. A patch placed on the forehead uses a 9-volt lithium battery stimulation that creates a "tingling sensation" on the skin between the eyebrows.[2] Jan Eastgate, president of CCHR International says, "With no FDA regulation of psychiatry,[3] this latest practice of zapping a lack of focus could send a wrong message to children. There are psychiatrists that would have them believe that electricity pulsing through their brain while they sleep may help control impulsive behavior." And pediatric neurologist, Dr. Fred Baughman advises parents that there is no proof that "ADHD" behavior has a medical or neurobiological cause.[4]

Recently, the FDA also cleared the usage of electroshock treatment—up to 460 volts of electricity through the brain—for adolescents aged 13 and above with "bipolar" disorder.[5]  Yet according to the FD&C Act, the "FDA does not regulate the practice of medicine."[6] As such, "How psychiatrists administer electroshock is a free-for-all license for potentially committing 'mental euthanasia' on anyone they please, including children," Eastgate adds. She called on people to sign CCHR's petition to ban ECT.

Freedom of Information requests CCHR filed in seven U.S. states reveal that psychiatrists are electroshocking kids aged five and younger.[7]

It is common for psychiatrists to say they don't know how ECT "works." In a petition to the FDA Commissioner in 2016, Constitutional attorney, Jonathon Emord noted, "How ECT 'works' and even if it works is highly disputed."[8]

Nor are there clinical studies proving safety and efficacy of ECT devices, Emord says.[9] Likewise, the exact mechanism of the Monarch eTNS System and its long term effects is unknown.[10] 

As Forbes pointed out: "There are nearly a dozen neurostimulation devices on the market that claim to improve cognitive function by allowing you to zap your brain with a small electrical current. But just because you can now do this at home doesn't mean it's a good idea. ECT uses electrical current in the range of 600-1000 milliamps.... But you're welcome to zap your brain with a much lighter touch of roughly 1-2 milliamps from the comfort of your couch for anywhere between $99 and $800 dollars. That is, if you don't mind leaving the state of your brain up to chance."[11]

The marketing hype fed parents for this new device is likely to go something like this, Eastgate says: The "zapping" ADHD device is a "noninvasive treatment" and less risky than cocaine-like amphetamines or stimulants currently prescribed to treat "ADHD." This avoids drug side effects like anorexia, poor growth and cardiovascular problems.[12] 

Jessica Baron, writing in Forbes noted, "While it's true that the [neurostimulation] electrodes don't penetrate your head, they must produce enough current to reach the brain in order to have any effect at all. Calling these products 'noninvasive' is merely a marketing technique and a misleading one if you ask me."[13]

Researchers do not understand the effects of long-term use of brain stimulation, but say that no brain region exists in isolation. Modulating one brain area may impact on other areas.[14]

Nick J. Davis Ph.D. from the Department of Psychology, Swansea University in the UK, explains that because the brain continues to develop until the age of 20, stimulation in children and adolescents would have a stronger impact.[15]

Davis said there is evidence that enhancing one aspect of cognition may be detrimental to other cognitive faculties. "There is also the worrying possibility that electrical stimulation of the skull may induce or inhibit bone growth, an issue of particular importance in children whose cranial bones are not yet fused. This latter possibility has not been explored in human volunteers in brain stimulation experiments," Davis wrote in 2014.[16]

Davis pleaded for "calm and caution" when opting for stimulation device use in children because serious effects of transcranial stimulation include seizure, mood changes or induction of hyper- or hypo-mania.

It's a "calm and caution" the FDA ignores, Eastgate alleges. The studies of the current ADHD device have been small—about 60 children, using the device or a placebo each night for four weeks only. [17] However, Carlos Peña, Ph.D., Director, Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health, said: "This new device offers a safe, non-drug option for treatment of ADHD in pediatric patients."[18]

Dr. Peña also said that the FDA's Final Order on the ECT device classification provides information on its "safe and effective use" of ECT devices.[19] 

Yet he was part of an FDA hearing in 2014 investigating the practice of aversive conditioning electrical devices to modify undesirable behavior.[20] In that case, the FDA recommended the device be banned, saying it subjected residents at the Judge Rotenberg Center in Massachusetts to "an unreasonable and substantial risk to public health."[21] For almost three decades the Center has been zapping its special-needs residents with a custom-designed electric shock machine that delivers charges of up to 41 milliamps—10 times the amperage used in most stun guns—to their legs, arms, hands, feet, fingers or torsos via electrodes on the skin.[22] In 2013, Juan Mendez, the UN's former special rapporteur on torture, concluded that the rights of students "subjected to electric shocks and physical means of restraints have been violated under the UN convention against torture."[23] 

CCHR says ongoing dangerous decisions by the FDA warrant a Congressional investigation into children and others potentially being put at substantial health and mental risk.

CCHR is a nonprofit mental health watchdog group dedicated to eliminating abuses committed under the guise of mental health. CCHR works to ensure patient and consumer protections are enacted and upheld as there is rampant abuse in the field of mental health. In this role, CCHR has helped to enact more than 180 laws protecting individuals from abusive or coercive mental health practices since it was formed 50 years ago. As a nonprofit, CCHR relies on memberships and donations to carry out its mission and actions to curb psychotropic drug use in foster care. Click here to support the cause.

Contact: Amber Rauscher, [email protected] or (323) 467-4242

[1] "FDA approves breakthrough medical device to treat ADHD in children," CBS News, 24 Apr. 2019, https://www.cbsnews.com/news/fda-approves-breakthrough-adhd-medical-device-to-treat-children/; "First medical device approved to treat children with ADHD," Philly Voice, 24 Apr. 2019, https://www.phillyvoice.com/first-medical-device-treat-adhd-no-drugs.

[2] https://www.reddit.com/r/tDCS/comments/1kpqpx/trigeminal_nerve_stimulation_tns_shows_promising/. 

[3] https://www.federalregister.gov/documents/2018/12/26/2018-27809/neurological-devices-reclassification-of-electroconvulsive-therapy-devices-effective-date-of, Section B, Response 9, "Comments on Reclassifying ECT Based on Safety and Effectiveness."

[4] Dr. Fred Baughman, Jr., "ADHD is Neither a Disease or a Disorder," BMJ, 2008;337:a1239, https://www.bmj.com/rapid-response/2011/11/02/adhd-neither-disease-or-disorder.

[5] https://www.federalregister.gov/documents/2018/12/26/2018-27809/neurological-devices-reclassification-of-electroconvulsive-therapy-devices-effective-date-of, Section B, Response 9, "FDA does not regulate the practice of medicine."

[6] https://www.federalregister.gov/documents/2018/12/26/2018-27809/neurological-devices-reclassification-of-electroconvulsive-therapy-devices-effective-date-of, Section B, Response 9, "Comments on Reclassifying ECT Based on Safety and Effectiveness."

[7] State records CCHR obtained through public records requests from Indiana, Iowa, Kentucky, Maryland, Oregon, Pennsylvania and Utah; https://healthimpactnews.com/2017/psychiatric-association-wants-fda-to-expand-electroshock-used-on-children-and-elderly/.

[8] http://emord.com/blawg/wp-content/uploads/2016/08/1-ECT-Citizen-Petition.pdf, page 30.

[9] Jonathon Emord, "To date, no human clinical trials have been required for a new ECT device to receive marketing clearance from the FDA under section510(k) of the FDCA" and "FDA declined to require manufacturers ever to provide PMA information demonstrating either safety or efficacy of these devices," http://emord.com/blawg/wp-content/uploads/2016/08/1-ECT-Citizen-Petition.pdf, page 4-5.

[10] Op. cit., Philly Voice.

[11] Jessica Baron, "At-Home Brain Stimulation - What Could Possibly Go Wrong?," Forbes, 16 Nov. 2018, https://webcache.googleusercontent.com/search?q=cache:ELNiLuAmUq0J:https://www.forbes.com/sites/jessicabaron/2018/11/16/at-home-brain-stimulation/+&cd=1&hl=en&ct=clnk&gl=us.

[12] Op. cit., CBS News.

[13] Op. cit., Jessica Baron.

[14] Nick J. Davis, "Transcranial stimulation of the developing brain: a plea for extreme caution," Frontiers in Human Neuroscience, 5 Aug. 2014, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122183/.

[15] Melissa Hogenboom, "Warning over electrical brain stimulation," BBC News, 24 Aug. 2014, https://www.bbc.com/news/health-27343047.

[16] Op. cit., Nick J. Davis.

[17] https://www.inverse.com/article/55140-monarch-etns-fda-approved.

[18] https://www.formularywatch.com/fda-approval/fda-clears-first-non-drug-option-treat-adhd-children.

[19] https://www.fda.gov/news-events/fda-brief/fda-brief-fda-takes-action-ensure-regulation-electroconvulsive-therapy-devices-better-protects, citing: "The reclassified uses for ECT devices into Class II are limited to the treatment of catatonia or a severe major depressive episode associated with major depressive disorder or bipolar disorder in patients age 13 years."

[20] https://www.cbsnews.com/htdocs/pdf/00_2014/08-2014/24-Hour-Meeting-Summary-Aversive-Conditioning-final4-28.pdf.

[21] https://www.npr.org/2019/01/23/687636057/massachusetts-school-defends-use-of-electric-shock-treatments.

[22] "'It's torture': critics step up bid to stop US school using electric shocks on children," The Guardian, 16 Nov. 2018, https://www.theguardian.com/us-news/2018/nov/16/judge-rotenberg-center-massachusetts-electric-shocks.

[23] Ibid.

Related Images

cchr-condemns-fdas-approval-of.jpg
CCHR Condemns FDA's Approval of Electricity-Zapping for "ADHD" Kids
Mental health watchdog group says electrical "treatment" creates harm

Related Links

Sign CCHR's Petition to Ban ECT

Find out more about the dangers of electroshock

SOURCE Citizens Commission on Human Rights

Related Links

https://www.cchrint.org

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.